At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 60 enrolled
Drug / intervention
XF-73 nasal gel +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase I/II Randomised, Double-blind, Placebo-controlled, Single Centre Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of Two Concentrations of XF-73 Nasal Gel in Healthy Subjects.
In Brief
A Phase 2 clinical trial evaluating XF-73 nasal gel, Placebo nasal gel, and 1 other intervention for Staphylococcus Aureus Infection. Completed, enrolled 60 participants across 1 site.
Detailed Summary
Study to determine the efficacy, safety and tolerability of two concentrations of XF-73 nasal gel in combination with body and face washing with chlorhexidine gluconate cloths in eradicating nasal carriage of Staphylococcus aureus.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStaphylococcus Aureus Infection
CountriesUnited Kingdom
Collaborators--
Timeline
Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartSep 2014
Primary CompletionNov 2014
First PostedNov 2014
TodayJul 2026
First PostedNov 4, 2014
Enrollment StartSep 1, 2014
Primary CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 11.7 years ago
Interventions
XF-73 nasal geldrug
Placebo nasal geldrug
Chlorhexidine gluconate 2% topical clothsother